These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36282174)

  • 1. Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.
    Wang L; Liu Z; Liang R; Wang W; Zhu R; Li J; Xing Z; Weng S; Han X; Sun YL
    Elife; 2022 Oct; 11():. PubMed ID: 36282174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of the interaction of antigen presentation during anti-tumour immunity and establishment of AIDPS systems in ovarian cancer.
    Sun W; Xu P; Gao K; Lian W; Sun X
    J Cell Mol Med; 2024 Apr; 28(8):e18309. PubMed ID: 38613345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning-based identification of a consensus immune-derived gene signature to improve head and neck squamous cell carcinoma therapy and outcome.
    Hu X; Dong H; Qin W; Bin Y; Huang W; Kang M; Wang R
    Front Pharmacol; 2024; 15():1341346. PubMed ID: 38666027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-derived identification of prognostic signature for improving prognosis and drug response in patients with ovarian cancer.
    Huan Q; Cheng S; Ma HF; Zhao M; Chen Y; Yuan X
    J Cell Mol Med; 2024 Jan; 28(1):e18021. PubMed ID: 37994489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Immune Infiltration-related Molecular Features in Ovarian Cancer Patients and Experimental Validation of Immune Response Molecular Mechanisms through Integrated WGCNA, Machine Learning, and Single-cell Sequencing Analysis.
    Yang J; Wen C; Li P; Yao M; Wang J
    Recent Pat Anticancer Drug Discov; 2024 Jul; ():. PubMed ID: 39034722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the immune escape mechanisms in gastric cancer patients based on the deep AI algorithms and single-cell sequencing analysis.
    Chen W; Liu X; Wang H; Dai J; Li C; Hao Y; Jiang D
    J Cell Mol Med; 2024 May; 28(10):e18379. PubMed ID: 38752750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning-based Framework Develops a Tumor Thrombus Coagulation Signature in Multicenter Cohorts for Renal Cancer.
    Feng T; Wang Y; Zhang W; Cai T; Tian X; Su J; Zhang Z; Zheng S; Ye S; Dai B; Wang Z; Zhu Y; Zhang H; Chang K; Ye D
    Int J Biol Sci; 2024; 20(9):3590-3620. PubMed ID: 38993563
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling.
    Chen D; Cao Y; Tang H; Zang L; Yao N; Zhu Y; Jiang Y; Zhai S; Liu Y; Shi M; Zhao S; Wang W; Wen C; Peng C; Chen H; Deng X; Jiang L; Shen B
    Theranostics; 2023; 13(10):3290-3309. PubMed ID: 37351165
    [No Abstract]   [Full Text] [Related]  

  • 9. Artificial intelligence-driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi-center integration analysis.
    Xu H; Liu Z; Weng S; Dang Q; Ge X; Zhang Y; Ren Y; Xing Z; Chen S; Zhou Y; Ren J; Han X
    Mol Oncol; 2022 Dec; 16(22):4023-4042. PubMed ID: 36083778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management.
    Liu Z; Xu H; Weng S; Guo C; Dang Q; Zhang Y; Ren Y; Liu L; Wang L; Ge X; Xing Z; Zhang J; Luo P; Han X
    Cancer Immunol Immunother; 2023 Mar; 72(3):599-615. PubMed ID: 35998003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
    Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
    J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a 6-gene prognostic signature to assess prognosis of patients with pancreatic cancer.
    Yang J; Shi W; Zhu S; Yang C
    Medicine (Baltimore); 2020 Sep; 99(37):e22092. PubMed ID: 32925750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
    Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
    Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma.
    Qin H; Abulaiti A; Maimaiti A; Abulaiti Z; Fan G; Aili Y; Ji W; Wang Z; Wang Y
    J Transl Med; 2023 Sep; 21(1):588. PubMed ID: 37660060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer.
    Guo Y; Wang R; Shi J; Yang C; Ma P; Min J; Zhao T; Hua L; Song Y; Li J; Su H
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37739440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive machine learning-based preoperative blood features predict the prognosis for ovarian cancer.
    Wu M; Gu S; Yang J; Zhao Y; Sheng J; Cheng S; Xu S; Wu Y; Ma M; Luo X; Zhang H; Wang Y; Zhao A
    BMC Cancer; 2024 Feb; 24(1):267. PubMed ID: 38408960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients.
    Osipov A; Nikolic O; Gertych A; Parker S; Hendifar A; Singh P; Filippova D; Dagliyan G; Ferrone CR; Zheng L; Moore JH; Tourtellotte W; Van Eyk JE; Theodorescu D
    Nat Cancer; 2024 Feb; 5(2):299-314. PubMed ID: 38253803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer.
    Xiao M; Liang X; Yan Z; Chen J; Zhu Y; Xie Y; Li Y; Li X; Gao Q; Feng F; Fu G; Gao Y
    Front Immunol; 2022; 13():803962. PubMed ID: 35222383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer.
    Liu Z; Guo C; Dang Q; Wang L; Liu L; Weng S; Xu H; Lu T; Sun Z; Han X
    EBioMedicine; 2022 Jan; 75():103750. PubMed ID: 34922323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.